Patent classifications
C08F226/02
COATING LIQUID
The present invention provides a coating liquid comprising a hydroxyl group-containing resin, an inorganic layered compound and a liquid medium, wherein an amount of sodium (Na) in the coating liquid is 2,500 ppm or less on a weight basis relative to a solids content of the coating liquid.
COATING LIQUID
The present invention provides a coating liquid comprising a hydroxyl group-containing resin, an inorganic layered compound and a liquid medium, wherein an amount of sodium (Na) in the coating liquid is 2,500 ppm or less on a weight basis relative to a solids content of the coating liquid.
CROSSLINKED ORGANIC ADDITIVE FOR WATERBORNE COATING COMPOSITIONS
Coating compositions are provided. In embodiments, a coating composition comprises a solvent system comprising water; a crosslinked organic additive in the form of particles and comprising a polymerization product of reactants comprising a multifunctional vinyl monomer comprising two or more vinyl groups; a binder; and optionally, one or more of a colorant and a wax. Methods of making and using the coating compositions are also provided.
CROSSLINKED ORGANIC ADDITIVE FOR WATERBORNE COATING COMPOSITIONS
Coating compositions are provided. In embodiments, a coating composition comprises a solvent system comprising water; a crosslinked organic additive in the form of particles and comprising a polymerization product of reactants comprising a multifunctional vinyl monomer comprising two or more vinyl groups; a binder; and optionally, one or more of a colorant and a wax. Methods of making and using the coating compositions are also provided.
PROCESS FOR MANUFACTURING PAPER OR CARDBOARD
This invention relates to a method for manufacturing a sheet of paper or cardboard, according to which, before forming said sheet, at least one N-vinylformamide polymer that is partially hydrolyzed in the form of an inverse emulsion is added, at one or more injection points, to a fibrous suspension in the presence of an anti-gelling agent, and having a cationic regain between 30 and 150%, the inverse emulsion having a weight ratio of partially hydrolyzed N-vinylformamide polymer to anti-gelling agent in the range between 1,000,000/5000 and 1,000,000/50,000.
PROCESS FOR MANUFACTURING PAPER OR CARDBOARD
This invention relates to a method for manufacturing a sheet of paper or cardboard, according to which, before forming said sheet, at least one N-vinylformamide polymer that is partially hydrolyzed in the form of an inverse emulsion is added, at one or more injection points, to a fibrous suspension in the presence of an anti-gelling agent, and having a cationic regain between 30 and 150%, the inverse emulsion having a weight ratio of partially hydrolyzed N-vinylformamide polymer to anti-gelling agent in the range between 1,000,000/5000 and 1,000,000/50,000.
POLYMERS, COMPOSITIONS AND METHODS FOR TREATING HYPERURICEMIA
The disclosure provides small molecule compounds, polymers, and compositions thereof, as well as methods for preparing such polymers and compositions. Also provided is a method of using the polymers or compositions thereof for binding uric acid or precursor thereof, and/or for treating hyperuricemia, gout, and/or diseases caused by hyperuricemia.
POLYMERS, COMPOSITIONS AND METHODS FOR TREATING HYPERURICEMIA
The disclosure provides small molecule compounds, polymers, and compositions thereof, as well as methods for preparing such polymers and compositions. Also provided is a method of using the polymers or compositions thereof for binding uric acid or precursor thereof, and/or for treating hyperuricemia, gout, and/or diseases caused by hyperuricemia.
COMPOSITIONS FOR AND METHOD OF TREATING ACID-BASE DISORDERS
The present disclosure provides, inter alia, pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. In certain embodiments, the pharmaceutical compositions contain nonabsorbable pharmaceutical composition and may be used, for example, to treat eubicarbonatemic metabolic acidosis.
COMPOSITIONS FOR AND METHOD OF TREATING ACID-BASE DISORDERS
The present disclosure provides, inter alia, pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. In certain embodiments, the pharmaceutical compositions contain nonabsorbable pharmaceutical composition and may be used, for example, to treat eubicarbonatemic metabolic acidosis.